Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

104.78 -0.16 (-0.16%)
Streaming Delayed Price Updated: 10:14 AM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Abbott Labs Stock Strength Rises Into New Percentile As Health Care Giant Expands Organically And Via Acquisition
Additionally, Chicago-based Abbott Labs stock carries a near-perfect 98 Composite Rating, putting it in the top 2% of all stocks. 
Via Investor's Business Daily
Shares Of Abbott Laboratories (ABT) Rise Above Previous 52-Week High
Abbott Laboratories (NYSE: ABT) traded today at a new 52-week high of $129.40. Approximately 642,000 shares have changed hands today, as compared to an average 30-day volume of 4.... 
Via Benzinga
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:... 
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Within the last quarter, Abbott Laboratories (NYSE:ABT) has ... 
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Analysts have provided the following ratings for Abbott Laboratories (NYSE: 
Via Benzinga
Why Shares of Quidel Surged 10% This Week
Demand for its COVID tests are rising with cases. 
Via The Motley Fool
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
This May Be Abbott's Billion-Dollar Opportunity
Abbott delivered bad news back in June. But the tide has turned. 
Via The Motley Fool
Exposures COVID-19
Abbott Says Amulet Superior To Boston Scientific's Watchman In Stroke Study
Abbott Laboratories (NYSE: ABT) has announced late-breaking data from the Amulet LAA Occluder IDE trial. The head-to-head study compared Abbott's Amplatzer... 
Via Benzinga
See Why CVS Is Limiting Purchase Of OTC COVID-19 Tests
CVS Health Corp (NYSE: CVS) is capping purchases of rapid, over-the-counter COVID-19 tests, with a maximum of six packages available online and four in its pharmacies. The... 
Via Benzinga
Exposures COVID-19
Healthcare Stocks Hit New Highs but Small Caps Lag
Many smaller cap biotech stocks trade on news and milestones and have no earnings so require more expertise in the field. 
Via Talk Markets
Abbott Destroyed Several COVID Test Cards, Now Faces Diminished Capacity: NYT
When demand for rapid COVID-19 screening dropped earlier this year, Abbott Laboratories (NYSE: ABT) lowered its financial outlook for full-year 2021 and ... 
Via Benzinga
Exposures COVID-19
AbbVie: Dividend Stock to Buy?!
The quest to find undervalued dividend stocks to buy in this hot stock market continues. The S&P 500 continues to trend higher and set record highs, even though we’ve had a few down days recently. 
Via Talk Markets
Topics Stocks
Exposures US Equities
FDA Approves Abbott's Atrial Fibrillation Device For LAA Occlusion
The 
Via Benzinga
Exposures Product Safety
How Spinoffs Affect Your Stocks
When stocks you own spins off a segment or division of its business, the company you own changes. This can change not only the future prospects of the company you own but also its historical... 
Via Talk Markets
2 Stocks That Could Turn $200,000 Into $1,000,000 in 10 Years
Both of these companies know something about beating the market. 
Via The Motley Fool
1 Healthcare Dividend Giant to Bank On Right Now
The pipeline and consistent dividend history of this Dividend Aristocrat mean its payout is likely to remain strong. 
Via The Motley Fool
Moderna’s (MRNA) Massive Market Cap
As could have been expected in the midst of a global pandemic, one of the most rapidly growing companies has been vaccine producer Moderna. 
Via Talk Markets
Got $5,000? Buy and Hold These 3 Market-Beating Stocks
They're likely to continue to outperform the market. 
Via The Motley Fool
Analyzing Abbott Laboratories's Unusual Options Activity
Shares of Abbott Laboratories (NYSE:ABT) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $120.62. Sentiment:... 
Via Benzinga
Understanding Abbott Laboratories's Unusual Options Activity
On Friday, shares of Abbott Laboratories (NYSE:ABT) saw unusual options activity. After the option alert, the stock price moved up to $120.16. Sentiment: BULLISH Option Type:... 
Via Benzinga
Analyzing Abbott Laboratories's Unusual Options Activity
Abbott Laboratories (NYSE:ABT) shares experienced unusual options activity on Friday. The stock price moved up to $120.17 following the option alert. Sentiment: BULLISH Option... 
Via Benzinga
Abbott Laboratories (ABT) Q2 2021 Earnings Call Transcript
ABT earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound
Abbott Laboratories Q2 profit more than doubled to $2.1 billion due to strength in its diagnostics business and a rebound in medical device sales. 
Via Talk Markets
Quest Q2 Earnings Ahead Of Expectation On Recovery Of Non-COVID Business, Issues Mixed FY21 Guidance
Quest Diagnostics Incorporated (NYSE: DGX) posted better-than-expected second-quarter results, as vaccinations and the lifting of lockdowns resulted in recovery in its... 
Via Benzinga
Abbott Labs Beats Second-Quarter Views, But Covid Testing Demand Dives
Abbott on Thursday reported adjusted earnings of $1.17 per share on $10.2 billion in second-quarter sales. But ABT stock dipped a fraction. 
Via Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
Abbott Q2 Profit More Than Doubles As Medical Device Sales Rebound
Abbott Laboratories (NYSE: ABT) Q2 profit more than doubled to $2.1 billion due to strength in its diagnostics business and a rebound in medical device sales. As... 
Via Benzinga
Abbott Laboratories: Q2 Earnings Insights
Shares of Abbott Laboratories (NYSE:ABT) decreased 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 105.26% over... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Earnings, Economic Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of the release of jobless claims data. The Dow Jones surged more than 280 points in the previous... 
Via Benzinga
Topics Stocks
Exposures US Equities
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.